University of Texas MD Anderson Cancer Center

The University of Texas MD Anderson Cancer Center (colloquially MD Anderson Cancer Center) is a comprehensive cancer center in Houston, Texas

COVID-19 Nasal Vaccine Candidate Effective at Preventing Disease Transmission

Could a polymer wafer placed under the tongue deliver vaccines?

Can activation of a distinct genetic pathway slow the progress of metastatic breast cancer?

‘Quadrapeutics’ works in preclinical study of hard-to-treat tumors

The first preclinical study of a new Rice University-developed anti-cancer technology found that a novel combination of existing clinical treatments can instantaneously detect and kill only cancer cells — often by blowing them apart — without harming surrounding normal organs. The research, which is available online this week Nature Medicine, reports that Rice’s “quadrapeutics” technology

‘Quadrapeutics’ works in preclinical study of hard-to-treat tumors

OHSU researchers develop new drug approach that could lead to cures for wide range of diseases

A team led by a longtime Oregon Health & Science University researcher has demonstrated in mice what could be a revolutionary new technique to cure a wide range of human diseases — from cystic fibrosis to cataracts to Alzheimer’s disease — that are caused by “misfolded” protein molecules. Misfolded protein molecules, caused by gene mutation,

OHSU researchers develop new drug approach that could lead to cures for wide range of diseases

New Screening Strategy May Catch Ovarian Cancer at Early Stages

A new screening strategy for ovarian cancer appears to be highly specific for detecting the disease before it becomes lethal. The strategy is described in a study published early online in Cancer, a peer-reviewed journal of the American Cancer Society. If verified in an ongoing clinical trial, it could potentially help save the lives of

New Screening Strategy May Catch Ovarian Cancer at Early Stages

‘Nanobubbles’ Plus Chemotherapy Equals Single-Cell Cancer Targeting

Up to 30 times more deadly to cancer cells Using light-harvesting nanoparticles to convert laser energy into “plasmonic nanobubbles,” researchers at Rice University, the University of Texas MD Anderson Cancer Center and Baylor College of Medicine (BCM) are developing new methods to inject drugs and genetic payloads directly into cancer cells. In tests on drug-resistant

‘Nanobubbles’ Plus Chemotherapy Equals Single-Cell Cancer Targeting

‘Good Cholesterol’ Nanoparticles Seek and Destroy Cancer Cells

High-density lipoprotein’s hauls excess cholesterol to the liver for disposal, but new research suggests “good cholesterol” can also act as a special delivery vehicle of destruction for cancer. Synthetic HDL nanoparticles loaded with small interfering RNA to silence cancer-promoting genes selectively shrunk or destroyed ovarian cancer tumors in mice, a research team led by scientists

‘Good Cholesterol’ Nanoparticles Seek and Destroy Cancer Cells

The Latest Bing News on:

University of Texas MD Anderson Cancer Center Research

Dr. Verstovsek on the Benefit of JAK Inhibitor Combos in Myelofibrosis
Pielenz Clinical Research Center for Myeloproliferative Neoplasms, chief, Section for Myeloproliferative Neoplasms, Department of Leukemia, Division of Cancer Medicine, The University of Texas MD ...
Doctors are seeing more advanced cancer cases related to pandemic-delayed screenings and treatment
Across the country, there have been fewer cancer screenings and barriers to getting treatment. Now, doctors worry that delays have led to patients arriving at their offices with advanced cancer.
Addressing Disparities in Cancer Care and Beyond: What Can Be Done Now?
When the American Society of Clinical Oncology (ASCO) updated its policy statement on cancer disparities and health equity a year ago, 11 years had passed since the organizations ...
Novel Procedure Considered an ‘Acceptable Method’ to Preventing Transmission of Hereditary Cancer Mutations to Children
The genetic testing procedure may aid people with a history of hereditary cancer from passing those genetic mutations on to future children.
Anti-Nausea Drug May Boost Survival for Some Cancer Patients
Boost Survival for Some Cancer Patients By Amy Norton HealthDay Reporter TUESDAY, (HealthDay News) -- Patients who undergo surgery for certain types of cancer may have better short-term survival if ...

The Latest Google Headlines on:

University of Texas MD Anderson Cancer Center Research

UT Austin and MD Anderson Form Partnership to End Cancer - UT News - UT News | The University of Texas at Austin
October 6, 2021
MD Anderson celebrates World Cancer Research Day, progress made to end cancer through research - Newswise
September 24, 2021
MD Anderson supports World Cancer Research Day and its efforts to promote cancer research - News-Medical.Net
September 25, 2021
MD Anderson and the Rare Cancer Research Foundation launch collaboration to accelerate the development of treatments for rare cancers - Newswise
September 30, 2021
MD Anderson Research Highlights for October 6, 2021 - Newswise
October 6, 2021

The Latest Bing News on:

University of Texas MD Anderson Cancer Center Discovery

New treatments changing the lives of people with breast cancer, and more promise lies ahead
University of Texas MD Anderson Cancer Center And some comes from financial ... The mystery of the death of a son of Danville, Jelani Day The discovery of Jelani Day’s body in the Illinois ...
MD Anderson and Schrödinger announce strategic research collaboration to accelerate development of WEE1 program
MD Anderson and Schrödinger, Inc. announced a two-year strategic research collaboration to optimize the development of Schrödinger's WEE1 inhibitor program, designed to target the WEE1 kinase.
MD Anderson and Schrödinger Announce Strategic Research Collaboration to Accelerate Development of WEE1 Program
TRACTION is a core component of MD Anderson’s Therapeutics Discovery division ... About MD Anderson The University of Texas MD Anderson Cancer Center in Houston ranks as one of the world's ...
Atalanta Therapeutics Strengthens Leadership Team with Key Appointments in R&D and Corporate Development
Atalanta Therapeutics, a biotechnology company pioneering new treatment options for neurodegenerative diseases, today announced the expansion of its leadership team with three new appointments: Morgan ...
AffyImmune Therapeutics Announces $30M Series A+ Financing from ORI Capital
AffyImmune Therapeutics, Inc., a clinical stage biotechnology company developing and deploying its Tune & Track platform for the use of CAR T cells to treat solid tumors, announced today the close of ...